Haemonetics Reported First Quarter Fiscal 2021 Financial Results
themarketsignal.com/Free-Report/HAE
RSI of Haemonetics Corporation (NYSE:HAE) is 19.96 and the stock looks bullish. The company reported financial results for first quarter of fiscal 2021. In Q1-21 the company reported $196 million revenue, decreasing 18% from a year before. There has been a 16% organic revenue decline. The earnings per diluted share in Q1-21 came in at $0.21. During the first quarter of fiscal 2021, the adjusted earnings per diluted share came in at $0.46.
The company generated $12 million Cash flow from operating activities during the first quarter of fiscal 2021. Free cash flow before restructuring & turnaround during the reported quarter came in at $11 million.
The company also reported 46.0% gross margin in Q1-21, down 260 basis points in comparison with Q1-20.
themarketsignal.com/Free-Report/HAE
RSI of Haemonetics Corporation (NYSE:HAE) is 19.96 and the stock looks bullish. The company reported financial results for first quarter of fiscal 2021. In Q1-21 the company reported $196 million revenue, decreasing 18% from a year before. There has been a 16% organic revenue decline. The earnings per diluted share in Q1-21 came in at $0.21. During the first quarter of fiscal 2021, the adjusted earnings per diluted share came in at $0.46.
The company generated $12 million Cash flow from operating activities during the first quarter of fiscal 2021. Free cash flow before restructuring & turnaround during the reported quarter came in at $11 million.
The company also reported 46.0% gross margin in Q1-21, down 260 basis points in comparison with Q1-20.
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.